Avacta Therapeutics
  • About
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Publications
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Publications
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
Home News Investors Page 2
filter by: view all | Blogs | Diagnostics | Investors | Podcasts and Videos | R&D Spotlights Series | Therapeutics

Investors

20 Oct 2025

Equity fundraise of £16 million

Investors
13 Oct 2025

Research & Development Spotlight Series, Episode 12

Investors | R&D Spotlights Series | Therapeutics
30 Sep 2025

Interim Results for the six months to June 30, 2025

Investors | Therapeutics
15 Sep 2025

Notice of Interim Results and Investor Presentation

Investors | Therapeutics
09 Sep 2025

Avacta’s pre|CISION® Platform Shortlisted for the Technology of the Year Award at the AIM Awards

Investors | Therapeutics
01 Sep 2025

Avacta Announces Completion of the Sale of Coris Bioconcept SRL

Diagnostics | Investors
29 Aug 2025

Amendments to the Convertible Bond and equity fundraise of £3.25 million

Investors | Therapeutics
28 Jul 2025

Avacta Announces Agreement to Sell Coris Bioconcept SRL

Diagnostics | Investors
21 Jul 2025

Payment of Convertible Bond Installment

Investors
17 Jul 2025

Equity fundraise of £3.25 million

Investors

Posts navigation

Older posts
Newer posts
Avacta Therapeutics
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Corporate Responsibility
  • Contact Us

Avacta Group plc

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3911 0353

Investor Enquiries

ICR Consilium
85 Gresham Street
London
EC2V 7NQ

 

Email

Twitter | Linkedin

©2026 Avacta Therapeutics. Registered company no. 06605196.